Related Experiment Video
Updated: Jan 10, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Hepatic steatosis/fibrosis related biomarkers in patients with metabolic dysfunction-associated steatotic liver
Zhi Peng1, Zijin Wang1, Juan Wang1
1Department of Gastroenterology, The First Affiliated Hospital of Jishou University, Jishou, China.
Aims:
To explore hepatic steatosis and fibrosis related biomarkers in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
Patients And Methods:
Total 158 patients with MASLD were tested with Fibroscan to measure hepatic steatosis value (CAP value) and liver fibrosis value (E value), and divided into mild group (31 cases), moderate (49 cases), and severe fatty liver group (78 cases) according to CAP value; no fibrosis group (106 cases), early fibrosis group (38 cases), and advanced fibrosis and cirrhosis group (14 cases) according to E value.
Results:
E value was negatively correlated with CHOL and LDL, and CAP value was positively correlated with LDL. TG, CHOL and LDL levels in severe fatty liver group were significantly higher than those in mild fatty liver group; TG and LDL levels in moderate fatty liver group were higher than those in mild fatty liver group. TG level in early fibrosis group was significantly higher than that in advanced fibrosis and cirrhosis group.
Conclusion:
With the aggravation of hyperlipidemia, hepatic steatosis increases; with the aggravation of liver fibrosis, TG level decreases. Lipid metabolism worsens with the degree of steatosis. LDL is related to the severity of hepatic steatosis and fibrosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

